These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 19602116)
1. Green tea catechin inhibits lipopolysaccharide-induced bone resorption in vivo. Nakamura H; Ukai T; Yoshimura A; Kozuka Y; Yoshioka H; Yoshinaga Y; Abe Y; Hara Y J Periodontal Res; 2010 Feb; 45(1):23-30. PubMed ID: 19602116 [TBL] [Abstract][Full Text] [Related]
2. Locally administered interferon-γ accelerates lipopolysaccharide-induced osteoclastogenesis independent of immunohistological RANKL upregulation. Ayon Haro ER; Ukai T; Yokoyama M; Kishimoto T; Yoshinaga Y; Hara Y J Periodontal Res; 2011 Jun; 46(3):361-73. PubMed ID: 21361961 [TBL] [Abstract][Full Text] [Related]
3. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
4. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity. Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591 [TBL] [Abstract][Full Text] [Related]
5. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
6. Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis Yang J; Tang R; Yi J; Chen Y; Li X; Yu T; Fei J FASEB J; 2019 Jun; 33(6):7261-7273. PubMed ID: 30857415 [TBL] [Abstract][Full Text] [Related]
7. Fluvastatin Inhibits Osteoclast Differentiation and Porphyromonas gingivalis Lipopolysaccharide-Induced Alveolar Bone Erosion in Mice. Pokhrel NK; Kim YG; Kim JY; Kim HH; Lee Y J Periodontol; 2017 Apr; 88(4):390-398. PubMed ID: 27858552 [TBL] [Abstract][Full Text] [Related]
8. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways. Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972 [TBL] [Abstract][Full Text] [Related]
9. Dual modulation of osteoclast differentiation by lipopolysaccharide. Zou W; Bar-Shavit Z J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834 [TBL] [Abstract][Full Text] [Related]
11. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Yamaguchi M; Uchiyama S Int J Mol Med; 2004 Jul; 14(1):81-5. PubMed ID: 15202020 [TBL] [Abstract][Full Text] [Related]
12. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue. Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594 [TBL] [Abstract][Full Text] [Related]
13. NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. Xing L; Bushnell TP; Carlson L; Tai Z; Tondravi M; Siebenlist U; Young F; Boyce BF J Bone Miner Res; 2002 Jul; 17(7):1200-10. PubMed ID: 12096833 [TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF-alpha, IL-1, and RANKL. Suda K; Woo JT; Takami M; Sexton PM; Nagai K J Cell Physiol; 2002 Jan; 190(1):101-8. PubMed ID: 11807816 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors. Strålberg F; Kassem A; Kasprzykowski F; Abrahamson M; Grubb A; Lindholm C; Lerner UH J Leukoc Biol; 2017 May; 101(5):1233-1243. PubMed ID: 28196851 [TBL] [Abstract][Full Text] [Related]
16. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722 [TBL] [Abstract][Full Text] [Related]
17. Icariin inhibits osteoclast differentiation and bone resorption by suppression of MAPKs/NF-κB regulated HIF-1α and PGE(2) synthesis. Hsieh TP; Sheu SY; Sun JS; Chen MH Phytomedicine; 2011 Jan; 18(2-3):176-85. PubMed ID: 20554188 [TBL] [Abstract][Full Text] [Related]
18. [Effect of lipopolysaccharide on osteoclasts formation and bone resorption function and its mechanism]. Zeng L; Xu Y; Xing G Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2018 May; 32(5):568-574. PubMed ID: 29806344 [TBL] [Abstract][Full Text] [Related]
19. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages. Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice. Hayashi S; Tsuneto M; Yamada T; Nose M; Yoshino M; Shultz LD; Yamazaki H Endocrinology; 2004 Jun; 145(6):2721-9. PubMed ID: 14988381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]